Showing 1-11 of 11 published briefings.
Company archive
Iperion (IPR) briefings
Read that company's published results in release order, newest first.
Loss narrowed 35.3% but cash fell 63.5% as Iperion's runway tightens
Operating losses keep absorbing the balance sheet; total equity fell 84.5% to NZ$0.1m while the Pathoglaze licence still produces no revenue.
Published 29 May 2026
Read briefingIperion's asset base fell to NZ$0.3m, the smallest on record
The half-year loss narrowed and cash burn eased, but with zero revenue the company is operating from its lowest asset base in the supplied historical
Published 28 April 2026
Read briefingLoss narrowed 45.3% but total assets fell to $0.5m unprecedented low
Zero revenue persisted while equity dropped 55.8% and the asset base hit a historical low, leaving runway as the dominant question.
Published 28 April 2026
Read briefingLoss narrowed 21.4% but equity fell 62.2% on continued zero-revenue burn
The smaller HY25 loss is cost-base contraction, not progress, with NZ$0.1m of cash facing a NZ$0.3m half-year operating burn.
Published 28 April 2026
Read briefingIperion's asset base shrank 99.9% to NZ$0.9m, leaving NZ$0.2m cash
The reported 99.7% NPAT improvement is a scale artefact: a near-complete contraction of the balance sheet leaves cash burn outrunning cash on hand.
Published 23 April 2026
Read briefingCash balance hit zero as the loss widened 250.8% on no revenue
An effectively dormant shell burned through its remaining NZ$0.7m of cash while the operating loss more than tripled to NZ$0.5m.
Published 23 April 2026
Read briefingIperion emerges as a $1.6m cash shell after issuer transition from SNC
The 99.8% PBT "improvement" reflects a completed transition out of a $2.0bn-asset predecessor, not operating progress in the new entity.
Published 23 April 2026
Read briefingPre-acquisition shell: cash builds to $0.7m, losses widen 23.4%
Interest income up 150% from a tiny base sets an unprecedented growth rate, but Southern Charter remains pre-revenue after the issuer transition.
Published 23 April 2026
Read briefingHeadline 99.9% PBT improvement masks transition to NZ$2.0m shell
Total assets fell from NZ$2,154.5m to NZ$2.0m through an issuer transition, leaving zero revenue and only NZ$22k of cash.
Published 23 April 2026
Read briefingIssuer transition strips SNC to a $2.1m acquisition shell
Headline -100.0% revenue and +99.8% loss narrowing reflect corporate change, not operating performance; NZ$44k cash limits acquisition capacity.
Published 23 April 2026
Read briefingIperion remains a NZ$2.1m cash shell with no operations deployed in FY21
An issuer transition from SNC and an unresolved acquisition search leave the read as a pre-deployment cash vehicle, not an operating result.
Published 23 April 2026
Read briefingGet reporting-season briefings
Get full NZX result briefings by email as new coverage is published.